Vitamin D sensitive EBNA-1 specific T cells in the cerebrospinal fluid of patients with multiple sclerosis

Journal of Neuroimmunology

Volumn 240-241, Issue , 2011, Pages 87-96

  Lossius, Andreas ^a,b   Vartdal, Frode ^a,b   Holmøy, Trygve ^c,d  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

Author keywords

Cerebrospinal fluid; EBNA 1; Epstein Barr virus; IL 17; Multiple sclerosis; Vitamin D

Indexed keywords

1,25 DIHYDROXYERGOCALCIFEROL; 25 HYDROXYVITAMIN D; EPSTEIN BARR VIRUS ANTIGEN 1; GAMMA INTERFERON; GLATIRAMER; HLA DR ANTIGEN; HLA DRB1 ANTIGEN; INTERLEUKIN 17; VITAMIN D;

ADULT; APOPTOSIS; ARTICLE; CASE REPORT; CD4+ T LYMPHOCYTE; CELL SPECIFICITY; CEREBROSPINAL FLUID; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; HAPLOTYPE; HUMAN; HUMAN CELL; LYMPHOCYTE CLONE; LYMPHOCYTE PROLIFERATION; LYMPHOID CELL LINE; MALE; MULTIPLE SCLEROSIS; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL; TH17 CELL;

ADULT; CELL LINE; CLONE CELLS; EPITOPES, T-LYMPHOCYTE; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; FEMALE; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MULTIPLE SCLEROSIS; T-LYMPHOCYTE SUBSETS; VITAMIN D; YOUNG ADULT;

EID: 83555179164     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2011.09.011     Document Type: Article

References (54)

1. Alotaibi S., Kennedy J., Tellier R., Stephens D., Banwell B. Epstein-Barr virus in pediatric multiple sclerosis. JAMA 2004, 291:1875-1879.
2. Ascherio A., Munch M. Epstein-Barr virus and multiple sclerosis. Epidemiology 2000, 11:220-224.
3. Bartosik-Psujek H., Tabarkiewicz J., Pocinska K., Stelmasiak Z., Rolinski J. Immunomodulatory effects of vitamin D on monocyte-derived dendritic cells in multiple sclerosis. Mult. Scler. 2010, 16:1513-1516.
4. Bickham K., Munz C., Tsang M.L., Larsson M., Fonteneau J.F., Bhardwaj N., Steinman R. EBNA1-specific CD4+ T cells in healthy carriers of Epstein-Barr virus are primarily Th1 in function. J. Clin. Invest. 2001, 107:121-130.
5. Bray P.F., Luka J., Culp K.W., Schlight J.P. Antibodies against Epstein-Barr nuclear antigen (EBNA) in multiple sclerosis CSF, and two pentapeptide sequence identities between EBNA and myelin basic protein. Neurology 1992, 42:1798-1804.
6. Cepok S., Zhou D., Srivastava R., Nessler S., Stei S., Bussow K., Sommer N., Hemmer B. Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis. J. Clin. Invest. 2005, 115:1352-1360.
7. Chen S., Sims G.P., Chen X.X., Gu Y.Y., Lipsky P.E. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J. Immunol. 2007, 179:1634-1647.
8. Cohen S.B., Katsikis P.D., Chu C.Q., Thomssen H., Webb L.M., Maini R.N., Londei M., Feldmann M. High level of interleukin-10 production by the activated T cell population within the rheumatoid synovial membrane. Arthritis Rheum. 1995, 38:946-952.
9. Correale J., Ysrraelit M.C., Gaitan M.I. Immunomodulatory effects of vitamin D in multiple sclerosis. Brain 2009, 132:1146-1160.
10. Del Prete G., De Carli M., Almerigogna F., Giudizi M.G., Biagiotti R., Romagnani S. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J. Immunol. 1993, 150:353-360.
11. Eskild A., Bruu A.L., Stray-Pedersen B., Jenum P. Epstein-Barr virus infection during pregnancy and the risk of adverse pregnancy outcome. BJOG 2005, 112:1620-1624.
12. Farrell R.A., Antony D., Wall G.R., Clark D.A., Fisniku L., Swanton J., Khaleeli Z., Schmierer K., Miller D.H., Giovannoni G. Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI. Neurology 2009, 73:32-38.
13. Gaudernack G., Lundin K.E. Rapid immunomagnetic phenotyping of cells. J. Immunogenet. 1989, 16:169-175.
14. Handel A.E., Giovannoni G., Ebers G.C., Ramagopalan S.V. Environmental factors and their timing in adult-onset multiple sclerosis. Nat. Rev. Neurol. 2010, 6:156-166.
15. Handel A.E., Williamson A.J., Disanto G., Handunnetthi L., Giovannoni G., Ramagopalan S.V. An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis. PLoS One 2010, 5:e12496.
16. Heller K.N., Upshaw J., Seyoum B., Zebroski H., Munz C. Distinct memory CD4+ T-cell subsets mediate immune recognition of Epstein Barr virus nuclear antigen 1 in healthy virus carriers. Blood 2007, 109:1138-1146.
17. Hestvik A.L., Skorstad G., Price D.A., Vartdal F., Holmoy T. Multiple sclerosis: glatiramer acetate induces anti-inflammatory T cells in the cerebrospinal fluid. Mult. Scler. 2008, 14:749-758.
18. Hickey W.F., Hsu B.L., Kimura H. T-lymphocyte entry into the central nervous system. J. Neurosci. Res. 1991, 28:254-260.
19. Hislop A.D., Taylor G.S., Sauce D., Rickinson A.B. Cellular responses to viral infection in humans: lessons from Epstein-Barr virus. Annu. Rev. Immunol. 2007, 25:587-617.
20. Holmoy T. Vitamin D status modulates the immune response to Epstein Barr virus: synergistic effect of risk factors in multiple sclerosis. Med. Hypotheses 2008, 70:66-69.
21. Holmoy T., Kvale E.O., Vartdal F. Cerebrospinal fluid CD4+ T cells from a multiple sclerosis patient cross-recognize Epstein-Barr virus and myelin basic protein. J. Neurovirol. 2004, 10:278-283.
22. Holmoy T., Moen S.M., Gundersen T.A., Holick M.F., Fainardi E., Castellazzi M., Casetta I. 25-Hydroxyvitamin D in cerebrospinal fluid during relapse and remission of multiple sclerosis. Mult. Scler. 2009, 15:1280-1285.
23. Holmoy T., Vartdal F. Cerebrospinal fluid T cells from multiple sclerosis patients recognize autologous Epstein-Barr virus-transformed B cells. J. Neurovirol. 2004, 10:52-56.
24. Jankovic D., Kullberg M.C., Feng C.G., Goldszmid R.S., Collazo C.M., Wilson M., Wynn T.A., Kamanaka M., Flavell R.A., Sher A. Conventional T-bet(+)Foxp3(-) Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. J. Exp. Med. 2007, 204:273-283.
25. Jaquiery E., Jilek S., Schluep M., Meylan P., Lysandropoulos A., Pantaleo G., Du Pasquier R.A. Intrathecal immune responses to EBV in early MS. Eur. J. Immunol. 2010, 40:878-887.
26. Kern F., Bunde T., Faulhaber N., Kiecker F., Khatamzas E., Rudawski I.M., Pruss A., Gratama J.W., Volkmer-Engert R., Ewert R., Reinke P., Volk H.D., Picker L.J. Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals. J. Infect. Dis. 2002, 185:1709-1716.
27. Lees J.R., Sim J., Russell J.H. Encephalitogenic T-cells increase numbers of CNS T-cells regardless of antigen specificity by both increasing T-cell entry and preventing egress. J. Neuroimmunol. 2010, 220:10-16.
28. Levin L.I., Munger K.L., Rubertone M.V., Peck C.A., Lennette E.T., Spiegelman D., Ascherio A. Temporal relationship between elevation of Epstein-Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis. JAMA 2005, 293:2496-2500.
29. Lunemann J.D., Edwards N., Muraro P.A., Hayashi S., Cohen J.I., Munz C., Martin R. Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis. Brain 2006, 129:1493-1506.
30. Lunemann J.D., Jelcic I., Roberts S., Lutterotti A., Tackenberg B., Martin R., Munz C. EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2. J. Exp. Med. 2008, 205:1763-1773.
31. Lunemann J.D., Munz C. EBV in MS: guilty by association?. Trends Immunol. 2009, 30:243-248.
32. Lunemann J.D., Tintore M., Messmer B., Strowig T., Rovira A., Perkal H., Caballero E., Munz C., Montalban X., Comabella M. Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis. Ann. Neurol. 2010, 67:159-169.
33. Lysandropoulos A.P., Jaquiery E., Jilek S., Pantaleo G., Schluep M., Du Pasquier R.A. Vitamin D has a direct immunomodulatory effect on CD8+ T cells of patients with early multiple sclerosis and healthy control subjects. J. Neuroimmunol. 2011, 233:240-244.
34. McGeachy M.J., Bak-Jensen K.S., Chen Y., Tato C.M., Blumenschein W., McClanahan T., Cua D.J. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat. Immunol. 2007, 8:1390-1397.
35. Morita Y., Yamamura M., Kawashima M., Harada S., Tsuji K., Shibuya K., Maruyama K., Makino H. Flow cytometric single-cell analysis of cytokine production by CD4+ T cells in synovial tissue and peripheral blood from patients with rheumatoid arthritis. Arthritis Rheum. 1998, 41:1669-1676.
36. Nociti V., Frisullo G., Marti A., Luigetti M., Iorio R., Patanella A.K., Bianco A., Tonali P.A., Grillo R.L., Sabatelli M., Batocchi A.P. Epstein-Barr virus antibodies in serum and cerebrospinal fluid from multiple sclerosis, chronic inflammatory demyelinating polyradiculoneuropathy and amyotrophic lateral sclerosis. J. Neuroimmunol. 2010, 225:149-152.
37. Pender M.P. Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases. Trends Immunol. 2003, 24:584-588.
38. Penna G., Adorini L. 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J. Immunol. 2000, 164:2405-2411.
39. Polman C.H., Reingold S.C., Edan G., Filippi M., Hartung H.P., Kappos L., Lublin F.D., Metz L.M., McFarland H.F., O'Connor P.W., Sandberg-Wollheim M., Thompson A.J., Weinshenker B.G., Wolinsky J.S. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann. Neurol. 2005, 58:840-846.
40. Provvedini D.M., Manolagas S.C. 1 Alpha,25-dihydroxyvitamin D3 receptor distribution and effects in subpopulations of normal human T lymphocytes. J. Clin. Endocrinol. Metab. 1989, 68:774-779.
41. Ramagopalan S.V., Hanwell H.E., Giovannoni G., Knappskog P.M., Nyland H.I., Myhr K.M., Ebers G.C., Torkildsen O. Vitamin D-dependent rickets, HLA-DRB1, and the risk of multiple sclerosis. Arch. Neurol. 2010, 67:1034-1035.
42. Ramagopalan S.V., Maugeri N.J., Handunnetthi L., Lincoln M.R., Orton S.M., Dyment D.A., Deluca G.C., Herrera B.M., Chao M.J., Sadovnick A.D., Ebers G.C., Knight J.C. Expression of the multiple sclerosis-associated MHC class II allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Genet. 2009, 5:e1000369.
43. Ransohoff R.M., Kivisakk P., Kidd G. Three or more routes for leukocyte migration into the central nervous system. Nat. Rev. Immunol. 2003, 3:569-581.
44. Sargsyan S.A., Shearer A.J., Ritchie A.M., Burgoon M.P., Anderson S., Hemmer B., Stadelmann C., Gattenlohner S., Owens G.P., Gilden D., Bennett J.L. Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis. Neurology 2010, 74:1127-1135.
45. Serafini B., Rosicarelli B., Franciotta D., Magliozzi R., Reynolds R., Cinque P., Andreoni L., Trivedi P., Salvetti M., Faggioni A., Aloisi F. Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J. Exp. Med. 2007, 204:2899-2912.
46. Serafini B., Severa M., Columba-Cabezas S., Rosicarelli B., Veroni C., Chiappetta G., Magliozzi R., Reynolds R., Coccia E.M., Aloisi F. Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation. J. Neuropathol. Exp. Neurol. 2010, 69:677-693.
47. Shiozawa S., Shiozawa K., Tanaka Y., Fujita T. 1 Alpha,25-dihydroxyvitamin D3 inhibits proliferative response of T- and B-lymphocytes in a serum-free culture. Int. J. Immunopharmacol. 1987, 9:719-723.
48. Skorstad G., Hestvik A.L., Vartdal F., Holmoy T. Cerebrospinal fluid T cell responses against glutamic acid decarboxylase 65 in patients with stiff person syndrome. J. Autoimmun. 2009, 32:24-32.
49. Smolders J., Damoiseaux J., Menheere P., Hupperts R. Vitamin D as an immune modulator in multiple sclerosis, a review. J. Neuroimmunol. 2008, 194:7-17.
50. Spach K.M., Hayes C.E. Vitamin D3 confers protection from autoimmune encephalomyelitis only in female mice. J. Immunol. 2005, 175:4119-4126.
51. Sundstrom P., Juto P., Wadell G., Hallmans G., Svenningsson A., Nystrom L., Dillner J., Forsgren L. An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study. Neurology 2004, 62:2277-2282.
52. Torkildsen O., Stansberg C., Angelskar S.M., Kooi E.J., Geurts J.J., van der Valk P., Myhr K.M., Steen V.M., Bo L. Upregulation of immunoglobulin-related genes in cortical sections from multiple sclerosis patients. Brain Pathol. 2010, 20:720-729.
53. Tsoukas C.D., Provvedini D.M., Manolagas S.C. 1,25-Dihydroxyvitamin D3: a novel immunoregulatory hormone. Science 1984, 224:1438-1440.
54. Uchida M., Ozonco K., Pike J.W. In vitro binding of vitamin D receptor occupied by 24R,25-dihydroxyvitamin D3 to vitamin D responsive element of human osteocalcin gene. J. Steroid Biochem. Mol. Biol. 1997, 60:181-187.